Trial intelligence / Profile preview

Remimazolam in cardiac surgery

NCT05041725Phase 4Unknown

Sponsor
Konkuk University Medical Center
Start
Nov 2021
Primary completion
Nov 2022
Modality
Small Molecules
01

Overview

A Phase 4 trial of remimazolam in coronary artery disease (CAD), sponsored by Konkuk University Medical Center. Status: unknown.

02

Drugs

remimazolam
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT05041725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05041725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call